TJ210

Latest

Morphosys and I-Mab can start clinical studies for MOR210 / TJ210

An important milestone for Morphsys and I-Mab’s MOR210 / TJ210 antibody project: The US FDA has approved the two companies’s…

Read More »
Back to top button